Variant report
Variant | esv1816245 |
---|---|
Chromosome Location | chr6:32345443-32349086 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2894252 | chr6:32345443-32345444 | Weak transcription Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs117966254 | chr6:32345447-32345448 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9268431 | chr6:32345514-32345515 | Weak transcription Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs2894253 | chr6:32345540-32345541 | Weak transcription Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs558081261 | chr6:32345576-32345577 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs567463021 | chr6:32345588-32345589 | Weak transcription Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2395153 | chr6:32345595-32345596 | Weak transcription Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs534759434 | chr6:32345603-32345604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9268432 | chr6:32345667-32345668 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs541481077 | chr6:32345697-32345698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563246238 | chr6:32345747-32345748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575458373 | chr6:32345749-32345750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546067535 | chr6:32345763-32345764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2395154 | chr6:32345776-32345777 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs557728728 | chr6:32345857-32345858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9268433 | chr6:32345891-32345892 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs184251171 | chr6:32345992-32345993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9501619 | chr6:32346075-32346076 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs189064743 | chr6:32346089-32346090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550703524 | chr6:32346119-32346120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs117146138 | chr6:32346129-32346130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141111765 | chr6:32346195-32346196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564478708 | chr6:32346197-32346198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576676243 | chr6:32346207-32346208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72843270 | chr6:32346213-32346214 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs145158207 | chr6:32346280-32346281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs62402699 | chr6:32346388-32346389 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs544376260 | chr6:32346407-32346408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565188555 | chr6:32346408-32346409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555965517 | chr6:32346413-32346414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9268434 | chr6:32346452-32346453 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs9268435 | chr6:32346491-32346492 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs147587211 | chr6:32346616-32346617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575173526 | chr6:32346621-32346622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9268436 | chr6:32346637-32346638 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs34588018 | chr6:32346661-32346662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564024810 | chr6:32346662-32346663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533002231 | chr6:32346663-32346664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9268439 | chr6:32346701-32346702 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs561500498 | chr6:32346728-32346729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529381400 | chr6:32346736-32346737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs3129946 | chr6:32346772-32346773 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs115593412 | chr6:32346785-32346786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1980495 | chr6:32346794-32346795 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs142207772 | chr6:32346817-32346818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143135498 | chr6:32346851-32346852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547992029 | chr6:32346915-32346916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553783143 | chr6:32346960-32346961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1980494 | chr6:32347016-32347017 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs187415413 | chr6:32347017-32347018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22844521 | CNVD |
Gestational infection | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Encephalopathy | 20692195 | CNVD |
Immune disease | 17576883 | CNVD |
Multiple myeloma | 16616336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:32342800-32355200 | Weak transcription | Stomach Mucosa | stomach |
2 | chr6:32344000-32361400 | Weak transcription | Fetal Stomach | stomach |
3 | chr6:32344200-32345800 | Enhancers | Fetal Intestine Large | intestine |
4 | chr6:32344200-32345800 | Enhancers | Fetal Intestine Small | intestine |
5 | chr6:32344200-32346200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr6:32345200-32345600 | Active TSS | Duodenum Mucosa | Duodenum |
7 | chr6:32345600-32345800 | Enhancers | Duodenum Mucosa | Duodenum |
8 | chr6:32345800-32355000 | Weak transcription | Duodenum Mucosa | Duodenum |